# TCN Prime Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tcn-prime-co

- Industry: Medical Devices & Equipment
- Headquarters: Tokyo, Japan
- Website: www.tcn-prime.jp
- Total disclosed funding: $0.8M
- Latest round: Seed (Jun 28, 2024)
- Investors on record: 2

## About

Founded in 2023 and based in Tokyo, Japan, TCN PRIME inc. operates as a medical device and equipment developing and selling company specializing in cardiovascular products. In July 2024, TCN PRIME inc. raised JPY 130 million in venture funding led by investors Osaka University Venture Capital and Kobe University Capital. The firm, as of July 2024, has a research facility at the Shiga Research Institute in Kusatsu City, Shiga Prefecture, and s led by its Representative Director, Shinya Miike.

TCN Prime engages in the development and commercialization of advanced healthcare solutions, particularly focusing on cardiovascular medicine. Their flagship projects include an ECMO catheter designed to minimize patient stress and a balloon (BAV) catheter for treating aortic valve stenosis, both addressing critical unmet needs in cardiovascular therapy.

## Funding rounds

- Seed, Jun 28, 2024, $0.8M — Osaka University Venture Capital, Kobe University Capital

## Investors

- Osaka University Venture Capital (https://capitalatlas.ai/funds/osaka-university-venture-capital) — Seed
- Kobe University Capital (https://capitalatlas.ai/funds/kobe-university-capital) — Seed